LIGHT SCIENCE TECHNOLOGIES HOLDINGS PLC — Earnings Release 2025

Apr 24, 2026

National Storage Mechanism | Additional information

RNS Number : 7283B

Light Science Tech. Holdings PLC

24 April 2026

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596 / 2014 WHICH FORMS PART OF UNITED KINGDOM LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Light Science Technologies Holdings plc

("LSTH", "Light Science", the "Company" or the "Group")

Final Results

Analyst Briefing & Investor Presentation

Notice of AGM

Light Science Technologies Holdings plc (AIM: LST), the innovative technology and manufacturing business providing real-world solutions targeting issues including global food security and fire safety, announces its audited results for the year ended 30 November 2025 (the "Period").

Financial Highlights

·      Revenue of £8.6m (2024: £12.0m)

o  Reflecting reshaping of the portfolio and the anticipated reduction in lower-margin Contract Electronics Manufacturing ("CEM") activity

·      Gross margin increased by 11.5% to 33.8% (2024: 30.3%)

o  As a result of continued shift to higher value opportunities

·      Loss before tax of £0.89m (2024: £0.03m)

o  Driven by timing effects in Passive Fire Protection ("PFP") contract conversion and the expected reduction in CEM's servicing of the pest control market

·      Group cash at 30 November 2025 was £0.7m (30 November 2024: £1.2m)

Operational Highlights

·      PFP division positioned for accelerated conversion of sales pipeline

o  Continued education of key stakeholders, including the Building Safety Regulator ("BSR"), on the benefits of Injectaclad

o  Increasing number of BSR applications on which Injectaclad is now being specified

o  Recent regulatory progress underpins expectations of a significantly improved H2 of FY2026

·      AgTech ("AGT") division continued to develop its product suite and relationships

o  Upgraded customers' control systems and associated infrastructure in over 30 commercial glasshouses in the UK

o  Engaged a new sales executive to support scaling of the sensorGROW product suite

o  Strengthened sensorGROW IP position, following grant of a patent for its environmental sensor

·      CEM division focused on de-risking high customer concentration and on entry into higher margin markets including defence, medical and healthcare opportunities

o  Increased operational efficiencies and diversified customer mix

o  More onshoring back to the UK expected as a result of global uncertainties and supply and logistics issues

Post-Period End Highlights

·      Raised £6.6m to fund acquisitions of RLUK Injection Ltd ("RLUK"), the remaining minority interest in UK Circuits and Electronics Solutions Limited  ("UK Circuits") and the remaining units of the Manchester property (announced on 11 March 2026)

·      RLUK incorporates Injectaclad Ltd ("Injectaclad") facilitating scalability of PFP division, increasing access to fire remediation projects and providing a new revenue stream as the solution patent holder and materials supplier to installers

o  Enhancing the Group's control over a critical asset and ability to scale revenue and further improve gross margins

o  A key part of the Group's strategy to become the market leader in the remediation of building cavity fire barriers

o  Recently published BSR Strategic Plan highlights the need to cut delays and expediate cladding remediation schemes

·      UK Circuits minority and property acquisitions

o  Giving the Group full control of the CEM division and eliminating rental costs

o  The Manchester property will also become a northern base for PFP distribution and training

·      AGT secured an additional university contract in Wales and extended its contract with Nottingham Trent University ("NTU"), adding £0.44m in new revenues for the current period

Outlook

·      The enlarged Group is strongly positioned to capture a greater share of value chain, and for accelerated growth, targeting higher margin larger contracts and increasing recurring revenues

·      Strategically placed for improved conversion, enhanced sales and a stronger performance in FY2026 as H2 growth opportunities underpin confidence, with management anticipating a strong second-half revenue delivery in PFP

Online Analyst Briefing: 10.00am, today

An online briefing for analysts will be held at 10.00am today.  Analysts interested in attending should contact Walbrook PR on [email protected] or 020 7933 8780.

Investor Presentation: 11.00am on Monday 27 April

Management will provide a live online presentation and host an investor Q&A session via the Investor Meet Company platform on the results and the Company's future prospects, at 11.00am on Monday 27 April. Investors can sign up for free and register to meet Light Science via the following link: 

https://www.investormeetcompany.com/light-science-technologies-holdings-plc/register-investor

Questions can be submitted pre-event via the platform or by emailing [email protected], or in real time during the presentation via the "Ask a Question" function.

Posting of Annual Report & Accounts and Notice of AGM

The Company will be posting its annual report & accounts, together with notice of AGM, to shareholders later today, with this document now available on its website.

The annual general meeting is to be held at 10 am on Friday, 22 May 2026 at Ednaston Park Business Centre, Painters Lane, Ednaston, Ashbourne, DE6 3FA.

Simon Deacon, CEO of LSTH, commented: "This was a transitional period for the Group with a focus on creating a platform for high-margin growth across all of our divisions. We rebalanced the sales mix, with PFP and AGT providing the most significant scope for growth, while we further de-risked the CEM division, which is now well positioned to enter Defence, Medical and Healthcare markets.

"The post period end acquisitions will be transformational for the Group, significantly enhancing our profile and ability to generate scale and further grow margins as we target mid-term revenues of c.£50m. We believe that our solutions will become ever more prominent as both legislation - with the recently published BSR Strategic Plan highlighting the need to expedite schemes -  and global issues set to underpin increased demand. Having successfully completed the £6.6 million fund raise and acquisitions we are well placed for a strong second half of the current financial year as we fully integrate Injectaclad into the Group, which will support growth for the years to come.

"I'd like to thank the current and new investors for their support in the next exciting phase of our development."

For additional information please contact:

Light Science Technologies Holdings plc Simon Deacon, Chief Executive Officer Jim Snooks, Chief Financial Officer Andrew Hempsall, Chief Operating Officer	www.lightsciencetechnologiesholdings.com via Walbrook PR
Shore Capital (Nominated Adviser and Broker) Stephane Auton / George Payne	+44 (0)20 7408 4050
Walbrook PR Ltd (Media & Investor Relations) Nick Rome / Marcus Ullker	Tel: +44 (0)20 7933 8780 or [email protected]

Notes to Editors:

About Light Science Technologies Holdings plc (www.lightsciencetechnologiesholdings.com)

Light Science Technologies Holdings plc ("LSTH") operates through three divisions: Passive fire protection ("PFP"); AgTech ("AGT") and contract electronics manufacturing ("CEM"). The Company is involved in the design, manufacturing, and installation of products and customized solutions spanning various industry sectors, with a focus on addressing global challenges related to food security, climate change, and fire protection, the Group is committed to developing robust solutions in these rapidly growing market sectors.

As both an installer and supplier of the fire resistant graphite barrier system Injectclad, the PFP division is strongly positioned to capture a growing proportion of the fire remediation market as the Buildings Safety Regulator ("BSR") backlog unblocks, enabling accelerated conversion of the Company's strong sales pipeline. The Injectaclad system is a solution for the retrospective installation of cavity fire barriers in buildings using a pumped system, thereby avoiding the need for full-scale façade removal. It addresses a significant problem in the UK's built environment, where thousands of buildings require remediation to meet fire safety standards. For more information please visit Cavity Fire Barrier Remediation System | Injectaclad Ltd

The Group's tailored AgTech solutions encompass control systems, grow lights, sensor technology, venting, and irrigation systems, catering to both UK and global customers. Key markets include indoor, vertical, glasshouses, polytunnels, and more recently wider applications in broadacre farming. Driving factors comprise global food and water shortages, a growing population, government policies promoting sustainable growth methods, heightened scrutiny of food production's impact on climate change, and a shift away from processed foods. Key markets span Eastern Europe, the Americas, Australasia, and select locations in the Middle East, with the Company expanding routes to market via low-cost, low risk distribution agreements globally. For more information please visit: Sustainable grow lights and sensor technology - Light Science Technologies

The CEM division excels in designing, procuring, and manufacturing high-quality electronic products, with a specialisation in Printed Circuit Boards. These products find application across diverse sectors such as audio, automotive, electronics, gas detection, lighting, pest control, telecommunications and AgTech. For more information please visit: Home | UK Circuits

The Group is strongly positioned across a range of high growth sectors with proven technologies and solutions. It is increasingly focused on high margin opportunities that will drive cash generation. Furthermore, it is positioned for accelerated growth, targeting larger contracts and increasing recurring revenues - as both legislation and global issues look set to underpin demand for its products, driving the Company towards sustained profitable growth.

Chairman's statement

FY2025 has been a year of disciplined execution and strategic repositioning for Light Science. While Group revenues reduced to £8.63m (2024: £12.04m), this reflected the deliberate reshaping of our portfolio and the anticipated reduction in lower-margin CEM activity. Importantly, the Group delivered a further improvement in gross margin to 33.8% (2024: 30.3%), demonstrating the continued success of our shift towards higher-value opportunities and our ongoing drive to operational efficiencies.

Although the Group recorded a loss before tax of £0.89m (2024: £0.03m), this was driven by timing effects in PFP contract conversion and the expected reduction in CEM's servicing of the pest control market.

Across the Group, we have sharpened our strategic focus. The PFP division continues to build momentum, supported by a growing sales pipeline and increasing industry recognition of the benefits of Injectaclad as a highly effective and durable solution for remediating building cavity fire barriers. With recent signs of regulatory blockages beginning to release, we expect significantly improved conversion rates in the second half of FY2026.

In the AGT division, we have taken decisive action to preserve a lean cost base until larger orders in the pipeline begin to convert, ensuring the division remains efficient and ready to scale.

In the CEM division, we are progressing towards defence, medical and healthcare accreditations, which will open access to higher-margin markets and reduce historical customer concentration.

Following the year end, the Group announced a transformational set of plans, including a successful £6.6m fundraising and the acquisitions of RLUK Injection Ltd ("RLUK Injection") and the remaining 10% minority interest in the CEM division's UK Circuits and Electronics Solutions Limited ("UK Circuits"), together with the associated property.

The acquisition of RLUK Injection secures the intellectual property and supply chain behind Injectaclad, enhancing the Group's control over a critical asset within the PFP division and materially improving our ability to scale in a market with substantial medium-term demand.

Consolidating full ownership of UK Circuits and acquiring the Manchester property further strengthens the Group's operational base and supports our strategy to expand into higher margin defence, medical and healthcare markets.

The Board believes these developments create a robust platform for sustained high-margin growth, reduce reliance on third parties and materially enhance the Group's medium-term prospects.

Dr Graham Cooley

Non-Executive Chairman

23 April 2026

Chief Executive's report

FY2025 was a transitional year for the Group, with progress made in strengthening margins, building substantial pipelines and repositioning the business for higher‑quality growth. While external factors impacted short‑term revenues, strategic actions taken during and after the period leave the Group well positioned for improved conversion and stronger performance in FY2026.

Commercial, Operational and Financial Highlights

The PFP division delivered £1.38m (2024: £1.78m) of revenue during the year with gross margins of 51.7% (2024: 53.3%). Contract conversion was significantly slower than anticipated due to delays in project application approvals at the Building Safety Regulator ("BSR"). The government has responded by moving, at the end of January 2026, responsibility for the BSR from the Health and Safety Executive, to become a standalone, arm's-length body within the Ministry of Housing Communities and Local Government ("MHCLG"). During the year, the PFP division's quoted pipeline grew significantly from approximately £9m at the start of the financial year to approximately £20m currently. Recent regulatory progress provides us with confidence that we will see accelerated conversion within the division in the second half of FY2026.

The AGT division delivered £0.97m (2024: £0.78m) of revenue during the year with a 43.0% (2024: 49.9%) gross margin. Focus has been split between upgrading customers' control systems and associated infrastructure in over 30 commercial glasshouses in the UK, and expanding international partnerships for our nurturGROW and sensorGROW product solutions. We have continued development of our sensor technology and software platform, to facilitate expansion through resellers, lowering the costs of market entry and providing opportunities to scale the business rapidly. The AGT division remains lean while we await conversion of the substantial quoted pipeline, currently worth over £34m. With a strengthened IP position, following grant of a patent for its environmental sensor, sensorGROW (as announced on 2 June 2025) and growing international interest resulting from increasing concerns over global food security driven by the current geopolitical and economic uncertainties around the world, AGT remains a key long-term growth engine for the Group.

The CEM division delivered £6.31m (2024: £9.51m) revenue during the year with gross margins of 28.4% (2024: 24.3%). CEM revenue reduced as a direct result of its largest customer in the pest control market bringing one of its products to end-of-life, as anticipated. Gross margin improved though, driven by operational efficiencies and a more diversified customer mix. Customer concentration within the CEM division, and the Group, reduced during the year from 49.2% to 30.4% of Group revenue, lowering overall risk exposure. Our priority for the short-term is to gain defence, medical and healthcare accreditations, enabling us access to higher-value markets and long-term contracts. We will continue to focus on a higher-margin customer mix and, as was experienced during the COVID pandemic, we expect to see more onshoring back to the UK as a result of global uncertainties and supply and logistics issues around the world.

Strategic Growth and Market Opportunity

Our focus for FY2025 was to shape the Group for growth, with a strong emphasis on the PFP division. While awaiting the backlog of project applications at the BSR to be released, we have continued educating key stakeholders, including the BSR, on the benefits of Injectaclad as an optimal solution for remediating cavity fire barriers, versus the substantially more expensive and disruptive alternative of removing building façades. During the year, we have run continuing professional development and training sessions for stakeholders, including the BSR, underpinning their understanding of the Injectaclad solution, particularly given the increasing number of BSR applications on which Injectaclad is now being specified. We plan to increase the number of Injectaclad CPD sessions during 2026 and continue to expand awareness and education throughout the industry.

There are estimated to be over 40,000 buildings in the UK alone potentially requiring remediation work, with an addressable market estimated to be worth over £4bn[1]. To date, approximately 150 buildings have been completed using the patented Injectaclad solution, providing a very solid experience base on which to scale.

The post-year-end acquisition of RLUK Injection, owner of the patented Injectaclad system, brings the entire value chain of the PFP division under the Group's control, significantly strengthening the Group's strategic position and materially enhancing our ability to scale revenue and improve already strong gross margins.

Within the AGT division, our UK growth strategy has been to increase the visibility of our turnkey offering to the current customer base, through a number of media channels. The project win for Nottingham Trent University ("NTU"), worth approximately £0.60m (announced on 27 October 2025 and updated on 30 March 2026) sees all three of our Group divisions join forces to deliver an innovative research centre for our customer, showcasing to the market the multiple capabilities and synergies across the Group.

Internationally we have seen our lighting products delivered into Germany and Poland during the year. We have engaged a new sales executive to support scaling of the sensorGROW product range through global distribution partners, and to convert the associated recurring revenues. We have continued to manufacture the sensorGROW product in house, through our CEM division, ensuring control of the process and costs.

The market opportunity in sensors is estimated to be worth approximately £3.6 billion globally and growing at a compound annual growth rate of 11.3%[2]. With the cost of fertiliser and other key inputs increasing globally, it has become more important than ever to manage resources usage with live data. Our system provides customers with control of these key inputs and gives them the tools to increase their crop yields.

Within the CEM division, we have focused on de-risking our customer base, particularly the high level of historic concentration from our largest customer in the pest control market. We have been re-positioning the business and working on gaining new customers in higher-value markets and towards the end of the year have successfully started servicing into a new market supplying digital signs for London transport.

Post year we acquired the remaining 10% shareholding in the CEM division's UK Circuits, along with the remaining two units of the Manchester property, giving the Group full control of the CEM division and eliminating rental costs. The site will also become a northern base for PFP distribution and training, supporting faster mobilisation and improved customer reach.

Central to our strategy is to gain the required accreditations to enter higher tiers of the defence, medical and healthcare markets: to this end, we have received defence industry specialist support to assist us in alignment of our procedures and processes. We have been working to a detailed framework to achieve readiness for the accreditations and our recent equity fundraise will be instrumental in providing the resources to continue our progression through the required gateways. Additionally, we have attended a number of defence shows during the year and have been establishing new contacts into a growing market with £31.7 billion spent directly with UK based businesses[3]. With increased geopolitical tensions throughout the world and significantly heightened global volatility, we see the defence market as a key growth target for the CEM division.

Finally, we have brought our marketing function back in house during the financial year and have seen resulting improvements in communications with Group customers and stakeholders.

Financial Review

Income Statement

The PFP division recorded a decrease in year-on-year revenue from £1.78m in FY2024 to £1.38m in FY2025, being impacted significantly from project delays caused by the backlog of approval applications within the BSR. Encouragingly, gross margins held consistently strong above 50% year-on-year, achieving 51.7% for the year (2024: 53.3%).

The AGT division saw revenue growth of 24.4% year-on-year, increasing from £0.78m in FY2024 to £0.97m in FY2025, with a gross margin delivery of 43.0% (2024: 49.9%). The Board continued with its strategy of creating and developing global partnerships alongside growing its well-established UK business upgrading glasshouse control systems and associated infrastructure.

The CEM division saw a reduction in year-on-year revenue from £9.51m in FY2024 to £6.31m in FY2025, resulting directly from its largest customer in the pest control market bringing one of its products to end-of-life, as anticipated. Significantly, gross margin continued to improve, increasing year-on-year from 24.3% to 28.4%, driven by a strong commercial focus and continued operational efficiencies gained from investment in equipment and systems. The Board continues to take various actions aimed at maintaining and improving margin generation.

At a Group level, whilst revenues reduced by 28.3% to £8.63m (2024: £12.04m), gross margin increased to 33.8% (2024: 30.3%).

Despite increased employee and marketing costs to support the Group's growth strategy, the Board continued to maintain control over overhead costs, with administrative expenses increasing only 8.0% from £3.34m to £3.60m, in the backdrop of continued inflationary pressures.

Group loss before tax increased from £0.03m to £0.89m, reflecting the effect of reduced Group revenue, albeit at significantly stronger gross margin delivery.

Balance Sheet

The Group continued to invest in developing the AGT division's core product offering, leading to additions in the year of £0.10m in intangible development assets. Ongoing development costs relating to sensorGROW's extended functionality into nitrous oxide and plant rootzones were partly covered by UKRI grants, so a further £0.06m of grant income has been deferred within the year in respect of these intangible assets, and is accordingly shown separately within other payables. Due to the slower than originally anticipated revenue growth over the preceding few years and historic working capital support for Light Science Technologies Ltd in the AGT division, an impairment provision of £2.59m (2024: £0.09m) was recognised in the Company only accounts, the consolidated Group accounts are unaffected by this provision.

Year-on-year inventory levels were broadly consistent at £0.74m (2024: £0.81m), with stockholding levels closely managed and predominantly allocated to specific customer orders.

Cash Flow

Cash and cash equivalents reduced to £0.72m as at 30 November 2025  (2024: £1.21m) with working capital facilities fully utilised (2024: £0.66m undrawn). Net debt increased to £0.95m (2024: £0.71m) and cash generated from operations for the full-year reduced to £0.52m (2024: £1.53m).

Outlook

Following the move of responsibility for the BSR at the end of January 2026, the regulator has recently published its Strategic Plan ("Plan") for 2026-2027[4], which highlights the need to cut delays and expedite cladding remediation schemes, (as announced by the Company on 9 April 2026). The Plan sets out an ambition to deliver decisions on a significant proportion of remediation applications within a 12-week timeframe (for non-complex cases), alongside measures to improve application quality, increase transparency, and streamline engagement with industry participants. Notably, the regulator has also stated 'building control approval will no longer be a blocker to fixing homes'.  

The Company welcomes the BSR's clear acknowledgement of current delays within the building safety approvals process and its stated commitment to improving throughput and reducing bottlenecks, and anticipates a strong second-half revenue delivery, as conversion of the approximately £20m sales pipeline starts to take effect.

The AGT division has made a solid start to the new financial year, with the NTU project worth approximately £0.6m now well underway, and additionally we announced a new contract award on 30 March 2026 for a university in Wales, worth approximately £0.3m. Both contracts provide our turnkey AgTech products and solutions, with revenues expected to be wholly recognised in FY2026.

Whilst preserving a lean cost base within the AGT division, our focus is to continue building relationships in the UK, servicing the 100-plus AgTech customers who have purchased its products and solutions. Furthermore, we will continue branching out internationally with distributors for our sensorGROW hardware and software, and as more sensorGROW installations are implemented, increasing recurring revenues will be delivered for the Group. Food security is becoming ever increasingly important, with the cost of food production spiraling due to the heightening levels of global geopolitical instability and volatility. Our sensorGROW hardware and live monitoring system helps reduce these input costs for commercial indoor growers and broadacre farmers across the world, in a market estimated to be worth approximately £3.6 billion globally, growing at a compound annual growth rate of 11.3%[5].

The CEM division has tracked in line with expectations for the new financial year to date and good progress has been made in preparation for the required accreditations, to enter higher tiers of the defence, medical and healthcare markets. As a result of increased global instability and geopolitical tensions, we see defence as a key growth market for the CEM division, with £31.7 billion spent last year in this sector, directly with UK based businesses[6].

The Group recently completed a £6.6m fundraising alongside three strategic acquisitions that will materially reshape its operational footprint.

The 100% acquisition of RLUK Injection, owner of the patented Injectaclad system, brings the entire value chain of the PFP division under Group control. This secures supply, protects margin, and enables the Group to accelerate growth by integrating product development, installation, and distribution. We believe the acquisition of RLUK Injection, owner of the patented Injectaclad system, will be a key step forward in our strategy to become the market leader in the remediation of building cavity fire barriers, with over 40,000 buildings estimated to require work in the UK alone. Injectaclad's strong financial performance and extensive testing credentials provide a powerful platform to scale in the UK, with an addressable market estimated to be worth over £4bn[7], and the potential to expand internationally.

Additionally, the remaining 10% shareholding in the CEM division's UK Circuits was acquired, along with the remaining two units of the Manchester property, giving the Group full control of the CEM division and eliminating rental costs. The site will also become a northern base for PFP distribution and training, supporting faster mobilisation and improved customer reach.

Given the heightened levels of global volatility, we will continue to steer the Group on a flexible and agile footing to best protect its financial position, whilst capitalising on opportunities. The Group's strengthened balance sheet and enlarged operational platform position us to pursue larger contracts, increase recurring revenues, and accelerate progress toward the Board's medium-term ambition of reaching £50m in Group revenues.

We will progress through FY2026 with a strengthened financial position, an expanded platform, and a clear strategy to deliver sustained profitable growth.

Simon Deacon

Chief Executive Officer

23 April 2026

Consolidated Statement of Comprehensive Income

For the year ended 30 November 2025

		2025	2024
Notes	£'000	£'000
Revenue	3	8,632	12,037
Cost of sales		(5,718)	(8,393)
Gross profit		2,914	3,644
Administrative expenses		(3,604)	(3,337)
Non-underlying administrative expenses		-	(127)
Other operating income		95	169
Operating (loss) / profit	4	(595)	349
Finance costs		(299)	(380)
Loss on ordinary activities before taxation		(894)	(31)
Income tax charge / (credit)	5	(70)	11
Loss and total comprehensive income for the year		(964)	(20)
Attributable to: The owners of the Company		(979)	(47)
Non-controlling interests		15	27
		(964)	(20)
Loss per share
Basic and diluted (pence)	6	(0.30)	(0.01)

Consolidated Balance Sheet

Registered Number: 12398098

As at 30 November 2025

	30 November 2025	30 November 2024
	£'000	£'000
Assets Non-current assets
Goodwill	921	921
Intangible assets	1,429	1,533
Property, plant and equipment	606	724
Right-of-use assets	429	473
	3,385	3,651
Current assets
Inventories	735	811
Trade and other receivables	1,425	2,616
Corporation tax receivable	-	26
Cash and cash equivalents	723	1,215
	2,883	4,668
Total assets	6,268	8,319
Liabilities Current liabilities
Borrowings	(850)	(893)
Trade and other payables	(1,745)	(2,341)
Corporation tax payable	(13)	-
Consideration payable	(459)	(395)
Lease liabilities	(176)	(151)
	(3,243)	(3,780)
Non-current liabilities
Borrowings	(425)	(595)
Trade and other payables	(362)	(346)
Consideration payable	(464)	(827)
Lease liabilities	(220)	(290)
	(1,471)	(2,058)
Total liabilities	(4,714)	(5,838)
Net assets	1,554	2,481
Capital and reserves attributable to the owners of the Company Share capital Share premium account Share based payment reserve	3,330 5,520 561	3,330 5,520 524
Warrant reserve	-	160
Merger reserve	(3,479)	(3,479)
Retained earnings	(4,790)	(3,971)
	1,142	2,084
Non-controlling interests	412	397
Total equity	1,554	2,481

Consolidated Statements of Changes in Equity

For the year ended 30 November 2025

	Share capital £'000	Share premium account	Share based payment reserve	Warrant reserve	Merger reserve	Retained earnings	Non- controlling interests	Total equity
	£'000		£'000	£'000	£'000	£'000	£'000	£'000
At 30 November 2024	3,330	5,520	524	160	(3,479)	(3,971)	397	2,481
Transactions with shareholders
Share based payments	-	-	37	-	-	-	-	37
Warrants - lapsed warrants	-	-	-	(160)	-	160	-	-
Total transactions with shareholders	-	-	37	(160)	-	160	-	37
Comprehensive income
(Loss)/profit for the year	-	-	-	-	-	(979)	15	(964)
Total comprehensive income	-	-	-	-	-	(979)	15	(964)
At 30 November 2025	3,330	5,520	561	160	(3,479)	(4,790)	412	1,554
	Share capital	Share premium account	Share based payment reserve	Warrant reserve	Merger reserve	Retained earnings	Non- controlling interests	Total equity
	£'000	£'000	£'000	£'000	£'000	£'000	£'000
At 30 November 2023	3,330	5,520	547	160	(3,479)	(3,980)	370	2,468
Transactions with shareholders
Share based payments	-	-	33	-	-	-	-	33
Share based payments - lapsed options	-	-	(56)	-	-	56	-	-
Total transactions with shareholders	-	-	(23)	-	-	56	-	33
Comprehensive income
(Loss)/profit for the year	-	-	-	-	-	(47)	27	(20)
Total comprehensive income	-	-	-	-	-	(47)	27	(20)
At 30 November 2024	3,3305	5,520	524	160	(3,479)	(3,971)	397	2,481

Consolidated Cash Flow Statement

For the year ended 30 November 2025

		2025	2024
	Notes	£'000	£'000
Cash flows from operating activities Loss after tax		(964)	(20)
Adjustments for: Depreciation of tangible assets	4	116	150
Depreciation of right-of-use assets	4	160	124
Amortisation and impairment of intangible assets	4	205	308
Loss on disposal of tangible and right-of-use assets		4	1
Foreign exchange loss	4	3	2
Unwind of discount on consideration		113	100
Interest payable - loan and leases		120	129
Taxation and RDEC credit	5	1	(55)
Share based payment		37	33
Changes in working capital: Decrease in inventory		76	589
Decrease/(increase) in trade and other receivables		1,262	(461)
(Decrease)/increase in trade and other payables		(583)	567
Cash inflow from operations		550	1,467
Tax (paid) / received	5	(31)	67
Net cash inflow from operating activities		519	1,534
Cash flows from investing activities Purchase of property, plant and equipment		(19)	(29)
Proceeds from disposal of property, plant and equipment		15	9
Acquisition - consideration paid		(412)	(261)
Purchase of intangible fixed assets		(101)	(281)
Purchase of right-of-use-assets		-	(16)
Net cash outflow from investing activities		(517)	(578)
Cash flows from financing activities
Repayment of loans		(350)	(302)
Proceeds from new loans		-	850
Lease payments		(197)	(154)
Net increase / (repayment) of working capital facilities		137	(1,020)
Interest paid on loans		(84)	(97)
Net cash outflow from financing activities		(494)	(723)
Increase in cash and cash equivalents		(492)	233
Cash and cash equivalents at the start of the year		1,215	982
Cash and cash equivalents at the end of the year		723	1,215

Notes to the financial statements

1          General Information          

In accordance with Section 435 of the Companies Act 2006, the Group confirms that the financial information for the years ended 30 November 2025 and 2024 are derived from the Group's audited financial statements and that these are not statutory accounts and, as such, do not contain all information required to be disclosed in the financial statements prepared in accordance with UK-adopted International Accounting Standards. The statutory accounts for the year ended 30 November 2024 have been delivered to the Registrar of Companies. The statutory accounts for the year ended 30 November 2025 have been audited and approved but have not yet been filed. The Group's audited financial statements for the year ended 30 November 2025 received an unqualified audit opinion and the auditor's report contained no statement under section 498(2) or 498(3) of the Companies Act 2006.

The financial information contained within this full year results statement was approved and authorised for issue by the Board on 23 April 2026. The 2025 accounts, together with notice of the Annual General Meeting, are expected to be posted to shareholders on 24 April 2026 and will be available from the Light Science Technologies Holdings plc website (www.lightsciencetechnologiesholdings.com) from the 24 April 2026. They will also be available from the Chief Financial Officer, Light Science Technologies Holdings plc, Ednaston Park Business Centre, Painters Lane, Ednaston, Ashbourne, DE6 3FA.

The Group financial statements have been prepared under the historical cost convention and under the basis of going concern. The principal accounting policies adopted are consistent with those disclosed in the financial statements for the year ended 30 November 2024.

2          Going concern

Working capital forecasts have been prepared by management which show that the Group can meet its day-to-day cash flow requirements and operate within all the terms of its borrowing facilities.

The Directors are satisfied that the Group has sufficient financing in place to continue to meet its liabilities as they fall due for a period of at least 12 months from the date of approval of this report and hence have prepared the financial statements on a going concern basis.

The Directors acknowledge that there is uncertainty on the level and timing of revenues especially in the AgTech and Passive Fire Protection divisions, and there would be a possible need to renegotiate the terms of its borrowing facilities or obtain a temporary covenant waiver, should the Group's expectations for revenue generation over the coming 12 months not materialise as expected. The Directors note that this material uncertainty may cast significant doubt on the Group's and Company's ability to continue as a going concern.

In response to these matters the Group is continuing to manage cash flows and discretionary spending.

The financial statements do not include any adjustments that would result if the Group and Company were unable to continue as a going concern.

3          Revenue and segmental reporting

The Group has three operating segments:

·      'Contract electronics manufacture' (CEM) relating to the development and manufacturing of electronic boards.

·      'AgTech' relating to the development, manufacturing and installation of lighting, technology and other products for the AgTech (AGT) sector.

·      'Passive fire protection' (PFP) relating to the installation of a retrospective cavity barrier in wall and floor constructions.

Corporate refers to the Group's centralised resources used by the segments. The Chief Operating Decision Maker (CODM) has been determined to be the Board. The performance of the three reportable segments is based upon a review of profits and segmental assets/liabilities.

The total revenue of the Group for the year has been derived from its principal activity wholly undertaken through operations in the United Kingdom and Republic of Ireland.

Revenue by geography:	2025 £'000	2024 £'000
United Kingdom	8,410	11,966
Europe	221	71
Rest of World	1	-
	8,632	12,037

Revenue in respect of the supply of hardware and project services is recognised at a point in time either at the point of customer collection, dispatch or project completion. Revenue in respect of services is recognised over time evenly over the number of months supported or as measured by the number of linear meters installed.

Revenue by products and services:	2025 £'000	2024 £'000
Supply of hardware (CEM)	6,307	9,514
Supply of hardware (AGT)	253	199
Supply of project services (AGT)	493	438
Supply of maintenance services (AGT)	219	141
Supply of installation services (PFP)	1,378	1,778
Intercompany eliminations	(18)	(33)
	8,632	12,037

During the year to 30 November 2025 one CEM customer represented 30.4% of total revenue (2024: 49.2%).

30 November 2025	Contract electronics manufacture	AgTech	Passive fire protection	Corporate and intercompany eliminations	Total
	£'000	£'000	£'000	£'000	£'000
Revenue	6,307	965	1,378	(18)	8,632
Gross profit	1,790	415	712	(3)	2,914
Depreciation, amortisation and impairment	(187)	(157)	(109)	(28)	(481)
Operating profit/(loss)	371	(318)	308	(956)	(595)
Segment assets	2,835	2,017	1,212	204	6,268
Segment liabilities	(2,540)	(788)	(982)	(404)	(4,714)

The corporate and intercompany eliminations operating profit/(loss) is greater than the prior year due to a reduction in intercompany management charges levied on the divisions.

30 November 2024	Contract electronics manufacture	AgTech	Passive fire protection	Corporate and intercompany eliminations	Total
	£'000	£'000	£'000	£'000	£'000
Revenue	9,514	778	1,778	(33)	12,037
Gross profit	2,314	388	947	(5)	3,644
Depreciation, amortisation and impairment	(193)	(281)	(94)	(14)	(582)
Operating profit/(loss)	639	(521)	633	(402)	349
Segment assets	4,128	2,321	1,743	127	8,319
Segment liabilities	(3,541)	(741)	(1,194)	(362)	(5,838)

4          Operating profit / (loss)

Operating profit/(loss) is stated after charging:	2025 £'000	2024 £'000
Depreciation on property, plant and equipment	116	150
Depreciation on right-of-use assets	160	124
Amortisation of intangible assets	205	181
Loss on sale of fixed assets	4	1
Impairment of intangible assets	-	127
Research and development expenses	13	26
Inventory expensed	4,046	6,261
Foreign exchange losses	3	2
Short term low value lease expenses	9	25
Share based payments	37	33

5          Taxation

The tax charge / (credit) is made up as follows:

	2025	2024
	£'000	£'000
Current tax expense
UK corporation tax for the year	13	(12)
Adjustment in respect of prior year	57	1
Total current income tax Deferred tax Origination and reversal of timing difference	70 -	(11) -
Adjustment in respect of prior year	-	-
	-	-
	70	(11)

Reconciliation of effective tax rate

The tax assessed for the year varies from the average standard rate of corporation as explained below:

	2025	2024
	£'000	£'000
Loss on ordinary activities before taxation	(894)	(31)
UK tax credit at average standard rate of 25% (2024: 25%)	(224)	(8)
Fixed asset differences	3	4
Expenses not deductible for tax	30	23
Adjustment to corporation tax in respect of prior periods	57	1
Adjustment for R&D tax credit including SME claims	-	(64)
Surrender of tax losses for R&D tax credit refund	-	11
Movement in deferred tax not recognised	204	22
Tax charge / (credit) in statement of comprehensive income	70	(11)

6          Loss per share

Basic loss per share is calculation on the loss for the year after taxation attributable to the owners of the parent of £978,496 (2024: £46,721) and on 324,105,500 ordinary shares (2024: 324,105,500), being the weighted number in issue during the year excluding shares held by the Employee Benefit Trust.

	30 November 2025			30 November 2024
	Loss £'000	Weighted average number of shares (000's)	Per share amount (pence)	Loss £'000	Weighted average number of shares (000's)	Per share amount (pence)
Basic and Diluted EPS
Weighted average number of ordinary shares		333,005,500			333,005,500
Adjusted for the effect of own shares held by Employee Benefit Trust (EBT)		(8,900,000)			(8,900,000)
Earnings attributable to ordinary shareholders of the Company	(979)	324,105,500	(0.30)	(47)	324,105,500	(0.01)

Diluted earnings per share

Basic and diluted earnings per share are equal for 2025 and 2024, since where a loss is incurred the effect of outstanding share options and warrants is considered anti-dilutive and is ignored for the purpose of the loss per share calculation.

7          Annual General Meeting

The annual general meeting is to be held at 10 am on Friday, 22 May 2026 at Ednaston Park Business Centre, Painters Lane, Ednaston, Ashbourne, DE6 3FA. Please refer to the Notice of AGM for full details.

---

[1] https://www.gov.uk/government/publications/building-safety-programme-estimates-of-ews1-requirements-on-residential-buildings-in-england/building-safety-programme-estimates-of-ews1-requirements-on-residential-buildings-in-england, over 40,000 buildings requiring an EWS1, multiplied by the average remediation cost to date of similarly sized buildings per management's calculations

[2] Agricultural Sensors Market 2032: (https://www.credenceresearch.com/report/agriculture-sensors-market): USD $4.8 billion by 2032 converted at GBP £1 = USD $1.35.

[3] https://www.gov.uk/government/news/british-economy-sees-defence-dividend-as-new-figures-reveal-above-inflation-increase-in-spend-with-industry

[4] https://www.gov.uk/government/publications/building-safety-regulator-strategic-plan-2026-to-2027

[5] Agricultural Sensors Market 2032: (https://www.credenceresearch.com/report/agriculture-sensors-market): USD $4.8 billion by 2032 converted at GBP £1 = USD $1.35.

[6] https://www.gov.uk/government/news/british-economy-sees-defence-dividend-as-new-figures-reveal-above-inflation-increase-in-spend-with-industry

[7] https://www.gov.uk/government/publications/building-safety-programme-estimates-of-ews1-requirements-on-residential-buildings-in-england/building-safety-programme-estimates-of-ews1-requirements-on-residential-buildings-in-england, over 40,000 buildings requiring an EWS1, multiplied by the average remediation cost to date of similarly sized buildings per management's calculations

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FR PPUBACUPQGAW